Angiotensin-(1-7) in hypertension

Current Opinion in Nephrology and Hypertension

Volumn 8, Issue 2, 1999, Pages 231-235

  Chappell, Mark C ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION;

EID: 0033045642     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199903000-00013     Document Type: Review

References (38)

1. 2 angiotensin receptor that recognizes the heptapeptide.
2. Chappell MC, Iyer SN, Diz DI, Ferrario CM. Antihypertensive effects of angiotensin-(1-7). Braz J Med Biol Res. 1998, 31:1205-1212 Review of the enzymatic pathways involved in the generation and metabolism of Ang-(1-7), as well as other angiotensins.
3. Deddish PA, Wang LX, Jackman HL, Michel B, Wang J, Skidgel RA, Erdos EG. Single-domain angiotensin I-converting enzyme (kininase II): characterization and properties. J Pharmacol Exp Ther. 1996, 279:1582-1589.
4. Corvol P, Michaud A, Soubrier F, Williams TA. Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertens. 1995, 13:S3-S10
5. Welches WR, Brosnihan KB, Ferrario CM. A comparison of the properties, and enzymatic activity of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci. 1993, 52:1461-1480.
6. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin 1 by neutral endopeptidase (EC 3.4 24.11) in spontaneously hypertensive rats. Hypertension 1992, 19:692-696.
7. Chappell MC, Pirro NT, Sykes A, Ferrario CM. Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension 1998, 31:362-367. Kinetic analysis of the metabolism of Ang-(1-7) by purified canine somatic ACE revealed a high substrate affinity (<1 μM) for the enzyme.
8. Deddish PA, Marcic B, Jackman HL, Wang H-Z, Skidgel RA, Erdos EG. N-domain specific substrate and C-domain inhibitors of angiotensin converting enzyme. Hypertension 1998, 31:912-917. The amino-terminal (N) domain of human somatic ACE exhibited a markedly higher catalytic rate for the hydrolysis of Ang-(1-7) than the carboxyl (C) domain. These studies indicate that Ang-(1-7) may be among a select number of peptides that are preferentially hydrolysed by the N domain of somatic ACE. At high concentrations (>1μM), Ang-(1-7) may function as a competitive inhibitor of the C domain.
9. Jones A, Diz DI, Ferrario CM, Chappell MC. Differential pathways for angiotensin-(1-7) metabolism in the lung and kidney (Abstract). Am J Hypertens. 1998, 11:32A.
10. 1/2>60 sec).
11. 7]-Ang-(1-7) antagonist, but enhanced by treatment with the ACE inhibitor enalaprilat.
12. Gorelik G, Carbini LA, Scicli AG. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery. J Pharmacol Exp Ther. 1998, 286:403-410.
13. 7]-Ang-(1-7). Both nitric oxide and prostaglandins apparently contributed to the effects of Ang-(1-7).
14. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasoditation by competing with ACE and releasing nitric oxide. Hypertension 1997, 29:394-400.
15. Hecker M, Blaukeat A, Bara AT, Muller-Esterl W, Busse R. ACE inhibitor potentiation of bradykinin-induced venoconstriction. Br. J. Pharmacol. 1997, 122:1475-1481.
16. Minshall RD, Tan F, Fumiaki N, Rabito SF, Becker RP, Marcic, Erdos EG, Potentiation of the actions of bradykinin by angiotensin I converting enzyme inhibitors Circ. Res 1997, 81:848-856. In cells transfected with human ACE and the kinin B2 receptor, ACE inhibitors potentiated the response to a peptidase resistant analog of bradykinin apparently by attenuating internalization of the kinin receptor.
17. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA, Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996, 28:104-108
18. Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth following vascular injury Hypertension 1998, 33: In press.
19. 1 antagonist losartan
20. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 1998, 31:356-361.
21. Yamada K, Iyer SN, Ferrario CM, Chappell MC. Prostaglandins mediate the anti-hypertensive effects of Angiotensin-(1-7) during chronic blockade of the renin-angiotensin system (Abstract). Am Soc of Hypertension 1998.
22. Iyer SN, Chappell MC, Ferrario CM, Angiotensin-(1-7) regulates the blood pressure in the spontaneously hypertensive rat (abstract). Hypertension 1998, 32:623.
23. Ichikawa I, Harris RC. Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int. 1991, 40:583-596.
24. Dellipizzi A, Hilchey SD, Bell-Quilley CP. Natriuretic actions of angiotensin-(1-7). Br J Pharmacol. 1994, 111:1-3.
25. 2 release. Hypertension 1995, 25:1238-1244.
26. Heyne N, Beer W, Muhlbauer B, Osswald H. Renal response to angiotensin-(1-7) in anesthetized rats (Abstract). Kidney Int 1995, 47:975-976.
27. Handa RK, Ferrano CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 1996, 270:F141-F147.
28. 7]-Ang-(1-7) alone increased sodium excretion
29. Ren YL, Garvin JL, Carretaro OA. Vasodilator action of angiotensin 1-7 (Ang 1-7) in the isolated afferent arteriole of the rabbit kidney (Abstract). J Nephrology 1998, 9.345A. Low doses of Ang-(1-7) induced rasodilation of the afferent arteriole isolated from the rabbit kidney. Inhibition of nitric oxide synthase by L-NAME blocked the actions of Ang-(1-7) while the cyclooxygenase inhibitor indomethacin did not alter the response.
30. Andreatla-Van Leyen S, Romero MF, Khosla MC, Douglas JG. Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int. 1993, 44:932-936
31. Garcia NH, Garvin JL. Angiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule. J Am Soc Nephrol. 1994, 5:1133-1138.
32. Vallon V, Richter K, Heyne N, Osswald H. Effect of intratubular application of Angiotensin 1-7 on nephron function. Kidney Blood Press Res 1997, 20:233-239.
33. Quan A, Baum M Endogenous production of Angiotensin II modulates rat proximal tubule transport. J Clin Invest. 1996, 97 2878-2882
34. Santos RAS, Silva AC, Magaldi AJ, Khosla MC, Cesar KR, Passaglio KT, Baracho NCV. Evidence for a physiological role of Angiotensin-(1-7) in the control of hydroelectrolyte balance Hypertension 1996, 27: 875-884.
35. Santos RAS, Baracho NCV. Angiotensin-(1-7) is a potent antidiuretic peptide in rats. Braz J Med Biol Res 1992, 25:651-654.
36. Baracho NCV, Silva ACS, Khosla MC, Santos RAS, Characterization of the antidiuretic action of angiotensin-(1-7) in water-loaded rats. Hypertension 1995, 25:1408.
37. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a Kinin-dependent mechanism. Hypertension 1998, 31:349-355
38. 1 blockade mediates a renal bradykinin nitric oxide cascade. Hypertension 1998; 32:629(Abstract)